Biosimilars are safe, effective medicines for patients that treat some of the most difficult-to-treat conditions such as psoriasis, rheumatoid arthritis and cancer. These important treatment options offer increased patient access and can potentially save the health care system billions of dollars. Interchangeable biologics are biosimilars that are approved by the FDA to be substituted by a third party for the reference biologic. Patients can rely on the safety of these products just as they would the reference medicine. Watch this important video to learn more about biosimilars, including:
- Biosimilars are clinically equivalent to their reference medicines. They are just as safe and just as effective as the biologic they are based on.
- Biosimilars are often available at a much lower cost than their biologic counterpart. Like all biologic medicines, a doctor prescribes a biosimilar to his or her patient.
- A doctor may prescribe a patient an interchangeable biologic.
- An interchangeable biologic is not superior in quality to a biosimilar product as both have to meet the very same high standards.
Watch this new video from the Biosimilars Council to learn more about biosimilars, biologics and interchangeability.